SummitDX
PrivateCompany Overview
SummitDX is a biotechnology company that develops saliva-based molecular diagnostic tests for the detection of head and neck cancer recurrence.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Medical Devices
Business Model
B2B
Customer Profile
Usage-Based SaaS, Services & Consulting
AI Layer
Non-AI
Keywords
liquid biopsymolecular diagnosticscancer recurrence detectionsaliva-based diagnosticshead and neck cancerbiomarker detectionnon-invasive testingprecision medicinectDNAdiagnostic testspit testcancer screeningbiotech startup
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SummitDX Comparables
Compare SummitDX with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| TeraDx | 87% | |
| OrisDX | 84% | |
| CareDx | 83% | |
SummitDX Funding Rounds
Historical fundraising activity
SummitDX Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about SummitDX's valuation, stock price, and market status.
See something wrong or outdated?